# Vanda Pharmaceuticals Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/vanda-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 21 | | Claims under review | 1 | | Evidence records | 4 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-23T04:47:12.694523+00:00 | | Last reviewed | 2026-10-23T04:47:12.694523+00:00 | ## Identity - Legal name: Vanda Pharmaceuticals Inc. - Display name: Vanda Pharmaceuticals Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-23T11:39:06.489073+00:00 | | Completeness | 0.409 | | Record Quality | 0.825 | | Directors | 10 | | Committees | 2 | | Governance events | 6 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Anne Sempowski Ward: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2019-01-01. claim_id=alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:6 - Charles C. Duncan: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-01-01. claim_id=alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:7 - Mihael H. Polymeropoulos: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2003-01-01. Committees: Granted in February 2026 (for 2025 Compensation) Committee (member). claim_id=alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:9 - Phaedra S. Chrousos: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2019-01-01. claim_id=alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:10 - Richard W. Dugan: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2005-01-01. claim_id=alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:11 - Stephen Ray Mitchell: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:12 - Charles C. Duncan, Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:8 - Mihael H. Polymeropoulos, M.D.: President, Chief Executive Officer and Chairman of the Board. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: Chief Executive Officer and Chairman of the Board (member). claim_id=alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:5 - Stephen Ray Mitchell, M.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:13 - Tage HonorĂ©, Ph.D., D.Sc.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:14 ## Committees - Chief Executive Officer and Chairman of the Board (executive). Chair: NOT_PUBLISHED. Members: Mihael H. Polymeropoulos, M.D. (member, unknown). committee_id=alpha:committee:vanda-pharmaceuticals-inc:chief-executive-officer-and-chairman-of-the-board - Granted in February 2026 (for 2025 Compensation) Committee (compensation). Chair: NOT_PUBLISHED. Members: Mihael H. Polymeropoulos (member, current). committee_id=alpha:committee:vanda-pharmaceuticals-inc:granted-in-february-2026-for-2025-compensation-committee ## Executive leadership - Gunther Birznieks: Senior Vice President, Business Development. Status: unknown. claim_id=alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:15 - Joakim Wijkstrom: Senior Vice President, Chief Marketing Officer. Status: unknown. claim_id=alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:16 - Kevin Moran: Senior Vice President, Chief Financial Officer and Treasurer [CFO]. Status: unknown. claim_id=alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:17 - Mihael H. Polymeropoulos, M.D.: President, Chief Executive Officer and Chairman of the Board [CEO]. Status: unknown. claim_id=alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:18 - Timothy Williams: Senior Vice President, General Counsel and Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:19 ## Governance events - DIRECTOR_APPOINTED: Charles C. Duncan seat on Vanda Pharmaceuticals Inc., effective 2026-01-01. Effective: 2026-01-01. Detected: 2026-10-23T04:47:12.694523+00:00. event_id=alpha:event:transition:1900qlah0qn7o - DIRECTOR_APPOINTED: Stephen Ray Mitchell seat on Vanda Pharmaceuticals Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-23T04:47:12.694523+00:00. event_id=alpha:event:transition:pxsiq4rpcj4u - DIRECTOR_APPOINTED: Anne Sempowski Ward seat on Vanda Pharmaceuticals Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-23T04:47:12.694523+00:00. event_id=alpha:event:transition:9ft34p7fvt5p - DIRECTOR_APPOINTED: Phaedra S. Chrousos seat on Vanda Pharmaceuticals Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-23T04:47:12.694523+00:00. event_id=alpha:event:transition:4oxn7s1fttx9i - DIRECTOR_APPOINTED: Richard W. Dugan seat on Vanda Pharmaceuticals Inc., effective 2005-01-01. Effective: 2005-01-01. Detected: 2026-10-23T04:47:12.694523+00:00. event_id=alpha:event:transition:3otlia1nkkd6e - DIRECTOR_APPOINTED: Mihael H. Polymeropoulos seat on Vanda Pharmaceuticals Inc., effective 2003-01-01. Effective: 2003-01-01. Detected: 2026-10-23T04:47:12.694523+00:00. event_id=alpha:event:transition:35x7e1xnbfhl ## Scoped resources - `alpha://company/vanda-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record - `alpha://company/vanda-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/vanda-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/vanda-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=board - `alpha://company/vanda-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/vanda-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/vanda-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/vanda-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/vanda-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/vanda-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/vanda-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/vanda-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/vanda-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/vanda-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/vanda-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/vanda-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/vanda-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/vanda-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/vanda-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/vanda-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=events - `alpha://company/vanda-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/vanda-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/vanda-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Granted in February 2026 (for 2025 Compensation) Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:mihael-h-polymeropoulos-vnda","name":"Mihael H. Polymeropoulos"},"source_id":"governance_people_committees"}` ## Leadership - Mihael H. Polymeropoulos, M.D.: President, Chief Executive Officer and Chairman of the Board. Claim: alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:376b8e44e4db555b17be06d8aba49e79e599cd7b9da5b2617048aca55acff4b8. - Anne Sempowski Ward: Director. Claim: alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:6. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8fd9e149c5d95a152ec721e835ea8cef960348948f01efd29d6a2f7332dc5f78. - Charles C. Duncan: Director. Claim: alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:7. Valid from: 2026-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8fd9e149c5d95a152ec721e835ea8cef960348948f01efd29d6a2f7332dc5f78. - Charles C. Duncan, Ph.D.: Director. Claim: alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:376b8e44e4db555b17be06d8aba49e79e599cd7b9da5b2617048aca55acff4b8. - Mihael H. Polymeropoulos: Director. Claim: alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:9. Valid from: 2003-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8fd9e149c5d95a152ec721e835ea8cef960348948f01efd29d6a2f7332dc5f78. - Phaedra S. Chrousos: Director. Claim: alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:10. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8fd9e149c5d95a152ec721e835ea8cef960348948f01efd29d6a2f7332dc5f78. - Richard W. Dugan: Director. Claim: alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:11. Valid from: 2005-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8fd9e149c5d95a152ec721e835ea8cef960348948f01efd29d6a2f7332dc5f78. - Stephen Ray Mitchell: Director. Claim: alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:12. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8fd9e149c5d95a152ec721e835ea8cef960348948f01efd29d6a2f7332dc5f78. - Stephen Ray Mitchell, M.D.: Director. Claim: alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:376b8e44e4db555b17be06d8aba49e79e599cd7b9da5b2617048aca55acff4b8. - Tage HonorĂ©, Ph.D., D.Sc.: Director. Claim: alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:376b8e44e4db555b17be06d8aba49e79e599cd7b9da5b2617048aca55acff4b8. - Gunther Birznieks: Senior Vice President, Business Development. Claim: alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:376b8e44e4db555b17be06d8aba49e79e599cd7b9da5b2617048aca55acff4b8. - Joakim Wijkstrom: Senior Vice President, Chief Marketing Officer. Claim: alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:376b8e44e4db555b17be06d8aba49e79e599cd7b9da5b2617048aca55acff4b8. - Kevin Moran: Senior Vice President, Chief Financial Officer and Treasurer. Claim: alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:376b8e44e4db555b17be06d8aba49e79e599cd7b9da5b2617048aca55acff4b8. - Mihael H. Polymeropoulos, M.D.: President, Chief Executive Officer and Chairman of the Board. Claim: alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:376b8e44e4db555b17be06d8aba49e79e599cd7b9da5b2617048aca55acff4b8. - Timothy Williams: Senior Vice President, General Counsel and Secretary. Claim: alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:376b8e44e4db555b17be06d8aba49e79e599cd7b9da5b2617048aca55acff4b8. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Granted in February 2026 (for 2025 Compensation) Committee: Chair not stated; Members Mihael H. Polymeropoulos. Claim: alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e56760eeb17f483fb14ab606c94afec2e0ee107dc583f6d5c1af620768778543. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Vanda Pharmaceuticals Inc.. Claim: alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ea2ff3aa839e7a91cb116f45cc8e2e836455e7bb4b7e93587e007f947cc56381. ## Entity Status - Public listing published. Claim: alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ea2ff3aa839e7a91cb116f45cc8e2e836455e7bb4b7e93587e007f947cc56381. ## Published Fact - US. Claim: alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ea2ff3aa839e7a91cb116f45cc8e2e836455e7bb4b7e93587e007f947cc56381. ## Committee Appointment - Mihael H. Polymeropoulos: member, Granted in February 2026 (for 2025 Compensation) Committee. Claim: alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e56760eeb17f483fb14ab606c94afec2e0ee107dc583f6d5c1af620768778543. ## Security Listing - VNDA (NASDAQ). Claim: alpha:claim:company:7bc1b655-1f18-4f22-85e3-69fae13fdce5:security_listing:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ea2ff3aa839e7a91cb116f45cc8e2e836455e7bb4b7e93587e007f947cc56381. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:ea2ff3aa839e7a91cb116f45cc8e2e836455e7bb4b7e93587e007f947cc56381: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc). - alpha:projection-evidence:document:376b8e44e4db555b17be06d8aba49e79e599cd7b9da5b2617048aca55acff4b8: [SEC DEF 14A 0001628280-26-026893](https://www.sec.gov/Archives/edgar/data/1347178/000162828026026893/vnda-20260423.htm). - alpha:projection-evidence:document:8fd9e149c5d95a152ec721e835ea8cef960348948f01efd29d6a2f7332dc5f78: [DEF 14A vnda-20260423.htm](https://www.sec.gov/Archives/edgar/data/1347178/000162828026026893/vnda-20260423.htm). - alpha:projection-evidence:e56760eeb17f483fb14ab606c94afec2e0ee107dc583f6d5c1af620768778543: [Granted in February 2026 (for 2025 Compensation) Committee](https://www.sec.gov/Archives/edgar/data/1347178/000162828026026893/vnda-20260423.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/vanda-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/vanda-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/vanda-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/vanda-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-23T11:39:06.250882+00:00; recorded 2026-10-23T11:39:06.250882+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.